Effects of green tea catechin on prostaglandin synthesis of renal glomerular and renal dysfunction in streptozotocin-induced diabetic rats

Asia Pacific Journal of Clinical Nutrition

Volumn 11, Issue 3, 2002, Pages 232-236

  Rhee, Soon Jae ^a   Kim, Mi Ji ^a   Kwag, Oh Gye ^b  

^a Catholic University of Daegu   (South Korea)

^b Taegu Science College   (South Korea)

Author keywords

Antithrombotic activity; Diabetes; Green tea catechin; Renal dysfunction; Renal glomerulus

Indexed keywords

ARACHIDONIC ACID; BETA 2 MICROGLOBULIN; CATECHIN; GREEN TEA EXTRACT; PROSTACYCLIN; PROSTAGLANDIN; STREPTOZOCIN; THROMBOXANE A2;

ANIMAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; CHEMISTRY; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; EXPERIMENTAL DIABETES MELLITUS; GLOMERULUS; GLOMERULUS FILTRATION RATE; KIDNEY DISEASE; KIDNEY FUNCTION; MALE; METABOLISM; NONHUMAN; PATHOPHYSIOLOGY; PROSTAGLANDIN SYNTHESIS; PROTEINURIA; RANDOMIZATION; RAT; RAT STRAIN; STREPTOZOCIN DIABETES; TEA; URINE;

ALBUMINURIA; ANIMALS; ARACHIDONIC ACID; BETA 2-MICROGLOBULIN; CATECHIN; DIABETES MELLITUS, EXPERIMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EPOPROSTENOL; GLOMERULAR FILTRATION RATE; KIDNEY DISEASES; KIDNEY GLOMERULUS; MALE; PROSTAGLANDINS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; TEA; THROMBOXANE A2;

ANIMALIA; GLOMERULUS;

EID: 0036379646     PISSN: 09647058     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-6047.2002.00312.x     Document Type: Article

References (29)

1. Brenner BM, Rector FC. Diabetic nephropathy. The kidney, 3rd edn. Philadelphia: WB Saunders, 1986: 1377-1402.
2. Cotran RS, Kumar V, Robbins SL. The kidney, pathologic basis of disease, 4th edn. Philadelphia: WB Saunders, 1989: 1044-1047.
3. Pedro C, Francis D, Jossse G, Nathan WL. Relationship between renal function and metabolic alteration in early streptozotocin-induced diabetes in rats. Diabetes 1987; 76: 80-87.
4. Schlondorff D, Arvaillou R. Prostaglandin and other arachidonic acid metabolites in kidney. Kidney Int 1986; 29: 108-119.
5. Linos EA, Andres GA, Dunn MJ. Glomerular prostaglandin and thromboxane synthesis in rat nephrotoxic serum nephritis. J Clin Invest 1983; 72: 1439-1448.
6. Purkerson ML, Hoffstein PE, Klahr S. Pathogenesis of the glomerulopathy associated with renal infection in rats. Kidney Int 1976; 9: 407-417.
7. Muramatsu K, Fukuyo M, Hara Y. Effect of green tea catechins on plasma cholesterol-fed rats. J Nutr Sci Vitaminol 1986; 32: 613-622.
8. Suzuki KT, Yaguchi K, Ohnuki R, Kishikawa M, Yamada YK. Extent of cadmium accumulation and its effect on essential metal in liver, kidney and body fluid. J Toxicol Environ Health 1983; 11: 713-726.
9. Sakanaka S, Kim M, Taniguchi M, Yamamoto T. Antibacterial substances in Japanese green tea extract against Streptococcus mutans a carcinogenic bacterium. Agric Biol Chem 1989; 53: 2307-2311.
10. Cheng SJ. The preliminary study of inhibitory effects of green tea antioxidant on mutation. Acta Exp Biol 1986; 9: 328-334.
11. 2 activity and antithrombus in streptozocin diabetic rats. J Nutri Sci Vitaminol 1999; 45: 337-346.
12. Kada T, Kaneko K, Matsuzaki S, Matsuzaki T, Hara Y. Detection and chemical identification of natural bioantimutagens. Mutat Res 1985; 50: 127-132.
13. Matsuzaki T, Hata Y. Antioxidative activity of tea leaf catechins. Nippon Nogeikagaku Kaishi 1985; 59: 129-134.
14. Yoon YH, Rhee SJ. Effect of Korean green tea, oolong tea and black tea beverage on the antioxidative detoxification mechanism in cadmium. Kor J Nutr 1994; 27 (10): 1007-1017.
15. Takahashi R, Morita I, Murata S, Ito H. Regulation of platelet aggregation and arachidonate metabolism in streptozotocin-diabetic rats. Prostaglandins Leukot Essent Fatty Acids 1986; 25: 123-130.
16. Kazuko N, Midori Y, Chikusa T, Michiko I, Mitsuo N. Platelet aggregation inhibitory activity of tea extracts. Nippon Shokuhin Kogyo Gakkaishi 1991; 38: 189-195.
17. Spiro RG. Studies on the renal glomerular basement membrane preparation and chemical composition. J Biol Chem 1967; 242 (8): 1915-1922.
18. Klahr S, Schreiner G, Ichikawa I. The progression of renal disease. N Engl J Med 1988; 318: 1657-1666.
19. 2 activity and the arachidonic acid cascade in kidney of diabetic rats. J Nutr 2001; 131: 1297-1301.
20. Particia FEM, Nievelstein PF, Sixma JJ, Wynne ORM, Groot HTD, Banga JD. Platelet adhesion and aggregate formation in type I diabetes under flow conditions. Diabetes 1991; 40: 1410-1417.
21. Parving HH, Oxenboll B, Svendsen PA, Christiansen JS, Anderson AR. Early detection of patients at risk of developing diabetic nephropathy. Acta Endocrinol 1982; 100: 550-555.
22. Nelsen RG, Knower WC, Pattit DJ, Saad MF, Charles MA, Bennett PH. Assessment of risk of overt nephropathy in diabetic patients from albumin excretion in untimed urine specimens. Arch Intern Med 1991; 151: 1761-1763.
23. Decker T, Feidt-Rasmussen B, Borch-Johnsen K, Jesan I, Koford Enevoldson A. Albuminuria reflects widespread vascular damage: the steno hypothesis. Diabetologia 1989; 32: 219-226.
24. 2-microglobulin determination in urine for the early detection of tubular proteinuria. Clin Chem Acta 1982; 126: 1-8.
25. 2-Microglobulin, its significance in the evaluation of the renal function. Kidney Int 1987; 32: 635-641.
26. Steffes MW, Osterby R, Chavers B, Mayer SM. Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients. Diabetes 1989; 38: 1077-1081.
27. Mogensen CE, Andersen MJF. Increased kidney size and glomerular filtration rate in early juvenile diabetes. Diabetes 1973; 22 (9): 706-712.
28. Butcher D, Kirkkawa R, Klein L, Miller M. Size and weight of glomeruli isolated from human diabetic and nondiabetic kidney. J Lab Clin Med 1977; 89: 544-553.
29. Rasch R. Prevention of diabetic glomerulopathy in streptozotocin diabetic rats by insulin treatment, kidney size and glomerular volume. Diabetologia 1979; 16: 125-128.